AI-generated summary
The authors report a randomized, double-masked study of 44 patients with meibomian gland dysfunction, in which one eye received intense pulsed light with gland expression and the other eye received a placebo treatment. Meibomian gland secretion and tear film break-up time improved after treatment, with greater gains in the treated eyes after the first and second sessions. The authors describe the treatment as efficient and safe, but the abstract reports only short-term results.
- Participants
- 44
- Who or what was studied
- Patients with meibomian gland dysfunction (MGD), with one eye treated and the fellow eye used as a placebo control
- Limits stated in the abstract
- The abstract reports only short-term outcomes from a single-center study of 44 patients, and it does not report the wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.